Surfactant treatment of extremely low birth weight (ELBW) infants

Applied Cardiopulmonary Pathophysiology

Volumn 6, Issue 1, 1996, Pages 11-17

  Svenningsen, N W ^b   Saugstad, O D ^a   Finna, P ^b   Danielsen, K ^b   Gronn M ^a   Holt, J ^a   Meberg, A ^b   Silberg, I E ^a   Okland O ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Extremely low birth weight (ELBW) infants; Natural porcine surfactant; Respiratory distress syndrome (RDS)

Indexed keywords

LUNG SURFACTANT EXTRACT; SURFACTANT;

ARTICLE; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENDOTRACHEAL INTUBATION; FEMALE; GESTATIONAL AGE; HUMAN; LOW BIRTH WEIGHT; MALE; MORTALITY; MULTICENTER STUDY; NEWBORN; OXYGEN TENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; SURVIVAL RATE;

EID: 0029979935     PISSN: 09205268     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Soll RF, McQueen MC. Respiratory distress syndrome: surfactant replacement therapy. In: Sinclair JC, Bracken MB (eds) Effective care of the new born infant. Oxford: Oxford University Press, 1992, pp 329-58.
2. Collaborative European Multicenter Study Group. Surfactant replacement therapy for severe respiratory distress syndrome: an international randomized clinical trial. Pediatrics 1988; 82: 683-91.
3. The OSIRIS Collaborative Group. Early versus delayed neonatal administration of a synthetic surfactant - the judgement of OSIRIS. Lancet 1992; 340: 1363-9.
4. Horbar JD, Wright LL, Soll RF, Wright EC, Fanaroff AA, Korones SB et al. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. J Pediatr 1993; 123: 757-66.
5. Horbar JD, Wright EC, Onstad L. Decreasing mortality associated with the introduction of surfactant therapy: an observational study of neonates weighing 601 to 1300 gram at birth. Pediatrics 1993; 92: 191-6.
6. Ferrara TB, Hoekstra RE, Couser RJ, Gaziano EP, Calvin SE, Payne NR, Fangman JJ. Survival and follow-up of infants born at 23 to 26 weeks of gestational age: effects of surfactant therapy. J Pediatr 1994; 124: 119-24.
7. Liechty EA, Donovan E, Purohit D, Gilhooly J, Feldman B, Noguchi A et al. Reduction of neonatal mortality after multiple doses of bovine surfactant on low birthweight neonates with respiratory distress syndrome. Pediatrics 1991 ; 88: 19-28.
8. Hoekstra RE, Jackson JC, Myers TF, Frantz ID, Stern ME, Powers WF et al. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. Pediatrics 1991 ; 88: 10-8.
9. Smyth J, Allen A, Sankaran K, MacMurray B, Peliowski A, Watson D et al. Effects of two rescuedoses of Exosurf Neonatal in 221 500-749 gram infants. Pediatr Res 1991 ; 29: 330A.
10. Kendig JW, Notter RH, Cox C, Reubens LJ, Davis JM, Maniscalco WM et al. A comparison of surfactant as immediate prophylaxis and as rescue therapy in neonates less than 30 weeks' gestation. N Engl J Med 1991 ; 324: 865-71.
11. Stevenson D, Walther F, Long W, Sell M, Pauly T, Gong A et al. Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. Pediatrics 1992; 120: S3-S12.
12. Dunn M. Surfactant replacement therapy: prophylaxis or treatment? Commentary. N Engl J Med 1993; 326: 148-50.
13. Halliday H, Tarnow-Mordi WO, Corcoran JD, Patterson CC. Multicentre ran demised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 trial). Arch Dis Child 1993; 69: 276-80.
14. Speer CP, Robertson B, Curstedt T, Halliday H, Compagnone D, Gefeller O et al. Randomized European multicenter trial of surfactant: replacement the rapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics 1992; 89: 13-20.
15. Papile LA, Burstein J, Burstein R, Koffler H. Incidence of evolution of subependy mal and intraventricular hemorrhage: a study of infants with birth weight less than 500 gram. J Pediatr 1978; 92: 529-34.
16. McClure G. Surfactant replacement therapy - time for thought. Controversy Arch Dis Child 1992; 67: 1228-30.
17. Halliday H, Tarnow-Mordi WO. Surfactant replacement-time for thought. Letter. Arch Dis Child 1993; 68: 619-20.
18. Jobe AH, Mitchell BR, Gunkel JH. Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants. Am J Obstet Gynecol 1993; 168: 508-13.
19. Gortner L, Pohlandt F, Bartmann P, Bernsau U, Potrz F, Hellwege HH et al. High-dose versus low-dose bovine surfactant treatment in very premature infants. Acta Paediatr 1994; 83: 135-41.
20. Egberts J, de Winter JP, Sedin G, deKleine MJK, Broberger U, van Bel F et al. Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial. Pediatrics 1993; 92: 768-74.
21. Soil RF, Sinclair JC, Bracken MB. Meta-analysis of surfactant trials: the effect of prophylactic surfactant versus surfactant treatment of established RDS. Pediatr Res 1993; 33: 276A.
22. Björklund L, Lindroth M, Svenningsen NW. Changing trend in respiratory support of ELBW infants in a level III NICU. Pediatr Res 1994; 35: 265A.
23. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundström K et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med 1994; 331(16): 1051-5.
24. Konishi M, Chida S, Shimada S, Kasai T, Murakami Y, Cho K et al. Surfactant replacement therapy in premature babies with respiratory distress syndrome: factors affecting the response to surfactant and comparison of outcome from 1982-86 and 1987-91. Acta Paediatr Jpn 1992; 34: 617-30.